CHRS
Coherus Oncology, Inc. Common StockRecent alerts on CHRS
All signals →
SEC filing
CHRS Reports 124.6M Votes for Proposals 1-3,5; 91.8M Votes for Proposal 4; $0 Broker Non‑Votes on Routine Items
1d ago
News
Coherus targets $15M quarterly LOQTORZI sales in 2026 while advancing midyear tagmokitug and casdozokitug readouts
21d ago
News
Coherus outlines $175M annualized LOQTORZI target by 2028 as commercial expansion accelerates
84d ago
News
Coherus BioSciences Q4 2025 Earnings Preview
85d ago
News
Coherus Oncology prices stock offering to raise $50.1M
109d ago
Get push alerts for CHRS
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS